Corneal Collagen Cross-Linking (CXL) by Avedro is an FDA-approved treatment therapy for keratoconus. This is an exciting new development in the field of eye care, as it is the only treatment that can effectively slow the progression of the debilitating disease. Keratoconus is characterized by a thinning, abnormally shaped cornea. As it worsens, the cornea bulges out further and scar tissue forms, which causes vision to gradually become more distorted. Although there is no cure for the disease, CXL can slow or stop its progression, offering new hope for patients living with keratoconus.
In the mild stages of keratoconus, glasses are typically sufficient for correcting blurry vision. However, as it progresses, further intervention may be necessary to preserve your vision and prevent the potential need for a corneal transplant. The doctors at Virginia Eye Consultants were participants in several trials by the FDA for CXL, and with its recent approval, we have become one of the first ophthalmology groups within Virginia to offer the solution.
Advantages of Corneal Cross-Linking
As the first and only treatment for progressive keratoconus, CXL offers advantages unlike any other solution. If you are good candidate for the treatment, you can experience the following benefits:
- Can slow or stop progression of keratoconus
- Has shown to slightly improve vision for many patients
- Non-invasive treatment
- Little to no discomfort
The Corneal Cross-Linking Treatment
The innovative cross-linking treatment takes about 30 minutes to complete and is virtually painless. It involves your doctor placing drops of riboflavin into the affected eye, after which you will lay under a light source to activate the formula. This combination acts to strengthen your cornea by increasing the cross-linking within the collagen of your eye.
Once the CXL process is done, you will be given a contact lens to wear. You will also be treated post-operatively with more eye drops to ensure proper healing and will return for a follow-up so our team can monitor your progress. Although you will still need to wear glasses or contact lenses to supplement your vision, it is possible that your prescription may change for the better. Most patients will experience a halt in their keratoconus progression, and studies have shown that CXL can even improve vision for many patients. Regardless of a potential vision improvement, you will still need routine follow-up refractive care.
Contact Virginia Eye Consultants
If you suffer from keratoconus and would like to learn if CXL can help preserve your vision, please contact us to set up an appointment.